140 related articles for article (PubMed ID: 22840747)
21. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury.
Higgins GC; Beart PM; Shin YS; Chen MJ; Cheung NS; Nagley P
J Alzheimers Dis; 2010; 20 Suppl 2():S453-73. PubMed ID: 20463398
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
Gibson GE; Haroutunian V; Zhang H; Park LC; Shi Q; Lesser M; Mohs RC; Sheu RK; Blass JP
Ann Neurol; 2000 Sep; 48(3):297-303. PubMed ID: 10976635
[TBL] [Abstract][Full Text] [Related]
24. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
Obulesu M; Rao DM
Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
[TBL] [Abstract][Full Text] [Related]
25. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
Swerdlow RH; Khan SM
Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
27. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide.
Viña J; Lloret A
J Alzheimers Dis; 2010; 20 Suppl 2():S527-33. PubMed ID: 20442496
[TBL] [Abstract][Full Text] [Related]
28. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.
Moreira PI; Carvalho C; Zhu X; Smith MA; Perry G
Biochim Biophys Acta; 2010 Jan; 1802(1):2-10. PubMed ID: 19853658
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer disease as a vascular disorder: where do mitochondria fit?
Correia SC; Santos RX; Cardoso S; Carvalho C; Candeias E; Duarte AI; Plácido AI; Santos MS; Moreira PI
Exp Gerontol; 2012 Nov; 47(11):878-86. PubMed ID: 22824543
[TBL] [Abstract][Full Text] [Related]
31. Etiology of type 2 diabetes and Alzheimer's disease: Exploring the mitochondria.
Silzer TK; Phillips NR
Mitochondrion; 2018 Nov; 43():16-24. PubMed ID: 29678670
[TBL] [Abstract][Full Text] [Related]
32. The key role of mitochondria in Alzheimer's disease.
Moreira PI; Cardoso SM; Santos MS; Oliveira CR
J Alzheimers Dis; 2006 Jul; 9(2):101-10. PubMed ID: 16873957
[TBL] [Abstract][Full Text] [Related]
33. The mitochondrial epigenome: a role in Alzheimer's disease?
Devall M; Mill J; Lunnon K
Epigenomics; 2014; 6(6):665-75. PubMed ID: 25531259
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's disease, Kuf's disease, tellurium and selenium.
Larner AJ
Med Hypotheses; 1996 Aug; 47(2):73-5. PubMed ID: 8869917
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment.
Ke J; Tian Q; Xu Q; Fu Z; Fu Q
Drug Discov Today; 2021 Aug; 26(8):1991-2002. PubMed ID: 33962036
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos RX; Correia SC; Wang X; Perry G; Smith MA; Moreira PI; Zhu X
Int J Clin Exp Pathol; 2010 Jun; 3(6):570-81. PubMed ID: 20661404
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's Disease: An Exacerbation of Senile Phenoptosis.
Isaev NK; Stelmashook EV; Genrikhs EE; Oborina MV; Kapkaeva MR; Skulachev VP
Biochemistry (Mosc); 2015 Dec; 80(12):1578-81. PubMed ID: 26638682
[TBL] [Abstract][Full Text] [Related]
38. Key role of mitochondria in Alzheimer's disease synaptic dysfunction.
Cavallucci V; Ferraina C; D'Amelio M
Curr Pharm Des; 2013; 19(36):6440-50. PubMed ID: 23432718
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease.
Cardoso S; Seiça RM; Moreira PI
Expert Rev Neurother; 2017 Jan; 17(1):77-91. PubMed ID: 27366815
[TBL] [Abstract][Full Text] [Related]
40. Toward Alzheimer therapies based on genetic knowledge.
Hardy J
Annu Rev Med; 2004; 55():15-25. PubMed ID: 14746507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
